Shiseido Company, Limited

Who owns Shiseido?
Shiseido is a publicly traded company listed on the Tokyo Stock Exchange under ticker 4911. The company has no controlling shareholder or parent company. Ownership is distributed among institutional investors, including Japanese trust banks, global asset managers, and foreign institutional investors. No individual, family, or corporate entity holds a controlling interest in the company.

Is Shiseido publicly traded?
Yes, Shiseido trades on the Tokyo Stock Exchange under ticker symbol 4911. The company has been publicly traded for decades and is one of the largest cosmetics companies listed on the Tokyo Stock Exchange by market capitalization. Shares can be purchased through securities firms that provide access to the Tokyo Stock Exchange.

Does Shiseido still own Drunk Elephant?
Yes, Shiseido acquired Drunk Elephant in 2019 for $845 million and continues to own the clean skincare brand. Drunk Elephant operates as a distinct brand within Shiseido's prestige portfolio, maintaining its focus on biocompatible ingredients and clean beauty principles. Drunk Elephant is one of Shiseido's fastest-growing brands, particularly in the United States and Asia.

What is Shiseido's revenue?
Shiseido reported FY2025 net sales of 980.4 billion yen, a 1.8% increase from 963.0 billion yen in FY2024. Core operating profit was 44.5 billion yen with a margin of 4.6%. Free cash flow was 66.5 billion yen. The company targets core operating profit margin of 7% or higher under its Shift 2025 and Beyond turnaround plan.

What is Shiseido's relationship to Issey Miyake?
Shiseido holds fragrance licenses for Issey Miyake and produces and distributes Issey Miyake fragrances globally. The Issey Miyake fragrance license is a significant contributor to Shiseido's fragrance business. Some other fragrance licenses that Shiseido historically held, including Narciso Rodriguez, have been transferred to other companies as Shiseido has focused on its core skincare and cosmetics business.

Who founded Shiseido?
Shiseido was founded in 1872 by Arinobu Fukuhara, a former head pharmacist for the Japanese Navy. He established Japan's first Western-style pharmacy in the Ginza district of Tokyo. The company's name is derived from a Chinese classic meaning "praise the virtues of the earth which nurtures new life." Shiseido began producing cosmetics in 1897 and has operated continuously for more than 150 years.

Shiseido was founded in 1872 by Arinobu Fukuhara, a former head pharmacist for the Japanese Navy, as Japan's first Western-style pharmacy in the Ginza district of Tokyo. The company's name is derived from a Chinese classic meaning "praise the virtues of the earth which nurtures new life," reflecting the founder's philosophy of combining Eastern aesthetics with Western science.

The company began producing cosmetics in 1897 with the launch of Eudermine, a skin lotion that is still sold today. Shiseido introduced its first toothpaste, Fukuhara Sanitary Toothpaste, in the same period, establishing the company's expertise in personal care products. Throughout the early 20th century, Shiseido expanded its beauty product offerings and became one of Japan's leading cosmetics manufacturers.

Shiseido's international expansion began in the 1960s and 1970s, with the company entering markets in Europe, North America, and across Asia. The company made several strategic acquisitions to build its prestige brand portfolio. In 2000, Shiseido acquired NARS Cosmetics, a professional makeup brand founded by Francois Nars. In 2010, the company acquired Bare Escentuals (bareMinerals) for $1.7 billion, though it later sold the brand to private equity firm Advent International in 2020 for approximately $250 million, reflecting a significant loss on the investment.

In 2019, Shiseido acquired Drunk Elephant, a clean skincare brand, for $845 million. The acquisition was part of Shiseido's strategy to expand its portfolio with high-growth, digitally native brands. Drunk Elephant has since become one of Shiseido's strongest performing brands, particularly in the United States and Asia.

In 2021, Shiseido transferred its personal care business, including the Tsubaki and SENKA brands, to a joint venture with CVC Capital Partners called FineToday Shiseido Holdings. Shiseido retained a 35% stake in the joint venture, allowing it to focus on its prestige beauty portfolio while maintaining exposure to the mass-market personal care segment.

In 2024, Kentaro Fujiwara was appointed as CEO, succeeding Masahiko Uotani. Fujiwara launched a comprehensive turnaround plan called "Shift 2025 and Beyond" focused on cost reduction, brand investment, and portfolio optimization. The plan targets 50 billion yen in cost savings by 2026 and aims to improve core operating profit margins to 7% or higher.

For FY2025, Shiseido reported net sales of 980.4 billion yen, up 1.8% from FY2024. Core operating profit of 44.5 billion yen exceeded the revised target, and free cash flow reached 66.5 billion yen. The company continues to face headwinds in China but has seen growth in its U.S. and Japanese markets.

Shiseido publishes an annual sustainability report covering its environmental, social, and governance performance. The company has committed to achieving carbon neutrality by 2050 and has set interim targets for reducing greenhouse gas emissions.

Shiseido is a signatory to the Science Based Targets initiative and has committed to reducing Scope 1 and 2 emissions by 2030. The company has invested in renewable energy for its manufacturing facilities and has implemented energy efficiency programs across its global operations. Shiseido reports its environmental performance data in accordance with global reporting frameworks including GRI and TCFD.

In product development, Shiseido has focused on sustainable packaging, including the use of recycled materials, refillable containers, and reduced plastic packaging. The company has set targets for increasing the proportion of sustainable packaging across its product lines and has made progress particularly in its Japanese personal care brands.

On ingredient sourcing, Shiseido has committed to ethical sourcing of key ingredients including palm oil, mica, and botanical extracts. The company is a member of the Roundtable on Sustainable Palm Oil (RSPO) and sources certified sustainable palm oil for its products. Shiseido also publishes its animal testing policy, stating that the company does not conduct animal testing except where required by law.

Shiseido's sustainability challenges include the environmental impact of its packaging, particularly single-use plastic containers for personal care products, and the carbon footprint of its global supply chain. The company's operations in China and Asia are subject to increasing environmental regulations, and the beauty industry as a whole faces growing consumer demand for sustainable and transparent product sourcing.

Shiseido has received recognition for its brand heritage, innovation, and sustainability practices.

• Dow Jones Sustainability Index: Shiseido has been included in the DJSI World and DJSI Asia Pacific indices, assessed annually by S&P Global for ESG performance among large-cap companies. The company has been a consistent constituent for multiple years.
• CDP Climate Change A-List: Shiseido has received recognition from CDP for its climate change disclosure and emissions management practices.
• Newsweek World's Most Trustworthy Companies (2025): Shiseido was recognized by Newsweek for corporate trustworthiness, reflecting its long heritage and reputation for quality.
• Clarivate Top 100 Global Innovators: Shiseido has been recognized for its patent filing activity and innovation in beauty and personal care formulations.
• Nikkei SDGs Management Survey: Shiseido has been ranked among Japanese companies with strong SDG-aligned management practices.

Shiseido has faced regulatory and public scrutiny related to ingredient safety, animal testing, and market-specific compliance issues.

Animal testing has been a persistent issue for Shiseido and other beauty companies selling in China. Chinese regulations previously required animal testing for all imported cosmetics, creating a conflict with the company's stated policy of avoiding animal testing except where legally required. In 2021, China relaxed its animal testing requirements for general cosmetics, allowing some imported products to bypass mandatory animal testing. Shiseido has stated that it is working toward eliminating animal testing globally while complying with local regulations where it operates.

In 2024, Shiseido faced scrutiny in China related to the discharge of treated wastewater from the Fukushima Daiichi nuclear power plant. Anti-Japan sentiment following the wastewater release led to consumer boycotts of Japanese beauty products, including Shiseido brands. The company's China sales declined significantly in 2023 and 2024 as a result, though sales have partially recovered in 2025 and 2026.

Shiseido has also faced regulatory actions related to product claims and advertising. In 2023, the company was required to modify advertising claims for certain skincare products in Japan after regulators determined that the claims were not adequately supported by clinical evidence. The company updated its product claims and compliance processes in response.

The Bare Escentuals acquisition and subsequent divestiture represents a significant financial misstep. Shiseido acquired the brand for $1.7 billion in 2010 and sold it for approximately $250 million in 2020, representing a loss of approximately $1.45 billion. The divestiture was part of Shiseido's strategy to focus on its prestige beauty portfolio and exit the mineral makeup category.